Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Condition: Head and Neck Cancer Intervention: Drug: TAK-981 Sponsors: Presage Biosciences; Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials